PhotoCure

Contact
photocure.no
+4722062210

PhotoCure ASA

Hoffsveien 48
0377 Oslo
Norway
+4722062210
photocure.no
Contact
Profile Products News
Contact

About PhotoCure

Photocure ASA is a Norwegian pharmaceutical company listed on Oslo Stock Exchange (PHO). The company develops and sells pharmaceuticals and medical devices based on proprietary photodynamic technology, targeting key dermatology and oncology markets.

Read more about PhotoCure
Facts about PhotoCure
  • Focus : Manufacturer
  • Industry : Pharma

Product portfolio of PhotoCure

Product portfolio

Show all

News about PhotoCure

PhotoCure

09-Jul-2012 | people

Photocure appoints Chief Financial Officer

Photocure ASA announced the appointment of Erik Dahl to its management team as the Chief Financial Officer, effective 15 August 2012.Dahl joins Photocure ...

Read news
PhotoCure

12-Jun-2012 | research and development

Photocure announces positive results of Phase 2B study evaluating Visonac in acne

Photocure ASA announced the results of the phase 2b study in acne with Visonac (methyl aminolevulinate 80mg/g), a topical acne treatment.  In this study, ...

Read news
PhotoCure

07-Mar-2012 | research and development

Photocure announces the achievement of the second transition milestone of EUR 1.5 million for Hexvix

Photocure ASA announced the achievement of the second manufacturing transition milestone from Ipsen, its new strategic partner for commercializing Hexvix ...

Read news
PhotoCure

11-Jan-2012 | people

Photocure strengthens its management team

Photocure ASA announces the appointment of Ambaw Bellete to its management team, as the Head US Cancer Commercial Operations.In his new role, Ambaw will ...

Read news
PhotoCure

13-Oct-2011 | research and development

Photocure announces the achievement of the first transition milestone for Hexvix

Photocure ASA announced the achievement of the first transition milestone from Ipsen, its new strategic partner for commercializing Hexvix worldwide, ...

Read news
PhotoCure

21-Jun-2011 | research and development

Photocure initiates enrolment into phase II trial of Cevira® for cervical HPV infection

First study to evaluate optimal dose of novel integrated drug-delivery device

Read news
PhotoCure

16-May-2011 | research and development

Photocure: Hexvix/Cysview demonstrates long term benefit

Results from 5.5 year follow up of recurrence of bladder cancer

Read news
PhotoCure

29-Apr-2011 | people

Photocure Strengthens the Management Team

Photocure  announced the appointment of Kathleen Deardorff, PharmD as Chief Operating Officer from May 1, 2011. In this role, Kathleen will report directly ...

Read news
Show more news about PhotoCure

Here you will find PhotoCure ASA